featured
Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impacts Clinical Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
J Urol 2020 Dec 01;204(6)1187-1194, D Deniffel, E Salinas, M Ientilucci, AJ Evans, N Fleshner, S Ghai, R Hamilton, A Roberts, A Toi, T van der Kwast, A Zlotta, A Finelli, MA Haider, N PerlisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.